WoundScribe AI
Share
X Facebook WhatsApp Email

Inside the Healing Trajectory Dashboard: Catching Stalled Wounds Before Week 4

analytics

Published

How the healing dashboard turns visit-over-visit measurements into an early-warning signal for stalled wounds and WISeR-ready evidence.

A wound that hasn't reduced 40–50% in area by week four is, statistically, a stalled wound. The problem isn't the rule — it's noticing in time. Between rotating clinicians, paper measurements, and charts that reset every visit, the trend line is usually invisible until it's a problem.

The healing dashboard exists to make that trend line the first thing you see.

What the dashboard tracks

  • Area over time — planimetric area from every Point-n-Capture image, plotted per wound, per patient.
  • Percent area reduction (PAR) — computed against the baseline capture, with the 40% / 50% benchmarks called out.
  • Tissue composition shifts — granulation up, slough down, or the reverse.
  • Conservative care duration — days on standard of care, ready to hand to a WISeR reviewer when it's time to escalate to advanced therapies.

The stalled-wound signal

When a wound's trajectory flattens, the stalled-wound detector flags it before week four — not after. That gives the clinician a real decision window: change the dressing protocol, add offloading, escalate to a skin substitute, or refer.

Why it matters for reimbursement

Payers increasingly want proof that conservative care was tried, measured, and failed before advanced therapies were billed. The dashboard is that proof — image-anchored, time-stamped, and exportable as part of the WISER claims and compliance bundle.

Where it sits in the workflow

Every capture from the exam room feeds the dashboard automatically. No re-entry, no separate analytics tool, no CSV export. The wound healing software is the same chart the clinician already signed.

For practices carrying a diabetic foot ulcer panel, that visibility is the difference between reacting at week eight and intervening at week three.